56396-35-1
56396-35-1 structure
- Name: UK-5099
- Chemical Name: (E)-2-cyano-3-(1-phenylindol-3-yl)prop-2-enoic acid
- CAS Number: 56396-35-1
- Molecular Formula: C18H12N2O2
- Molecular Weight: 288.300
- Catalog: Signaling Pathways Membrane Transporter/Ion Channel Monocarboxylate Transporter
- Create Date: 2018-12-20 14:31:44
- Modify Date: 2024-01-02 10:22:52
-
UK-5099 is a potent inhibitor of the mitochondrial pyruvate carrier (MPC). UK-5099 ihibits pyruvate-dependent O2 consumption with an IC50 of 50 nM.
| Name | (E)-2-cyano-3-(1-phenylindol-3-yl)prop-2-enoic acid |
|---|---|
| Synonyms |
CS-1048
(2E)-2-Cyano-3-(1-phenyl-1H-indol-3-yl)acrylic acid 2-Propenoic acid, 2-cyano-3-(1-phenyl-1H-indol-3-yl)-, (2E)- UK-5099 2-Cpiya |
| Description | UK-5099 is a potent inhibitor of the mitochondrial pyruvate carrier (MPC). UK-5099 ihibits pyruvate-dependent O2 consumption with an IC50 of 50 nM. |
|---|---|
| Related Catalog | |
| Target |
IC50: 50 nM (MPC)[1] |
| In Vitro | The trypanosomal pyruvate carrier is found to be rather insensitive to inhibition by alpha-cyano-4-hydroxycinnamate (Ki=17 mM) but can be completely blocked by UK-5099 (Ki=49 microM)[2]. UK-5099 also inhibits the monocarboxylate transporter (MCT) [3]. UK5099 significantly inhibits the glucose-stimulated rise in oxygen consumption in a dose-dependent manner and at 150 μM reduced oxygen consumption below basal levels. UK5099 reduces ATP levels and increases ADP and AMP levels in 832/13 cells[4]. The UK5099 treated cells show significantly higher proportion of side population fraction and express higher levels of stemness markers Oct3/4 and Nanog. UK5099 application may be an ideal model for Warburg effect studies[5]. |
| In Vivo | The MPC inhibitor UK5099 increases the glucose excursion seen during an intraperitoneal glucose tolerance test in C57BLK mice[4]. |
| Cell Assay | The 832/13 cell line derived from INS-1 rat insulinoma cells is used for experiments. Cell viability is measured using CellTiter Blue. The assay is based on cellular reduction of resazurin to resorufin. Appearance of resorufin is monitored by fluorescence emission at 585 nm using a Spectramax M5 microplate reader with excitation at 555 nm. For UK5099-treated cells, cells are allowed to recover for 1 h before measuring cell viability. Data are expressed as -fold relative to no treatment or siCtrl[4]. |
| Animal Admin | C57BLK mice are fasted for 16 h prior to glucose challenge. UK5099 (32 μmol/kg of body weight) or DMSO in PBS is injected into the intraperitoneal cavity 30 min before injecting glucose (1.5 mg of glucose/g of body weight). Blood glucose levels are measured at 0, 10, 20, 30, 60, and 120 min after glucose injection[4]. |
| References |
| Density | 1.2±0.1 g/cm3 |
|---|---|
| Boiling Point | 448.6±45.0 °C at 760 mmHg |
| Molecular Formula | C18H12N2O2 |
| Molecular Weight | 288.300 |
| Flash Point | 225.1±28.7 °C |
| Exact Mass | 288.089874 |
| PSA | 68.85000 |
| LogP | 4.60 |
| Vapour Pressure | 0.0±1.1 mmHg at 25°C |
| Index of Refraction | 1.634 |
| Storage condition | -20℃ |
| Hazard Statements | H413 |
|---|---|
| RIDADR | NONH for all modes of transport |